Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Although the pharmacokinetics (PK) and pharmacodynamics (PD) of high-dose human regular U-500 and human regular U-100 insulin are similar, the U-500 formulation may…
NEW YORK (Reuters Health) – Diuretic use is associated with an increased incidence of gout, an association mediated by increases in serum urate levels, according to findings published…
NEW YORK (Reuters Health) – Early administration of tranexamic acid (TXA) improves survival following severe combat trauma involving massive bleeding, according to a study in Archives of Surgery.…
NEW YORK (Reuters Health) – Among pediatric patients undergoing surgical repair of congenital heart defects, the use of milrinone to reduce the risk of low cardiac output syndrome…
NEW YORK (Reuters Health) – The dyspnea related to use of ticagrelor rather than clopidogrel in patients with acute coronary syndromes (ACS) is not associated with pulmonary function,…
NEW YORK (Reuters Health) – More than two-thirds of patients prescribed pitavastatin after an acute MI achieve target LDL cholesterol levels, and clinical outcomes are generally favorable, according…
NEW YORK (Reuters Health) – While fluoroquinolones may be a preferred option in children in some clinical situations, concerns about safety persist and physicians should be aware of…
NEW YORK (Reuters Health) – Pretreatment with a 600-mg versus a standard 300-mg loading dose of clopidogrel in the setting of urgent percutaneous coronary intervention for ST-segment elevated…
NEW YORK (Reuters Health) – An observational study conducted in the Netherlands finds that unexplained acute pancreatitis is often associated with drugs that can cause the condition, but…
NEW YORK (Reuters Health) – Treating patients with ischemic stroke up to 22 hours after onset with the glycoprotein IIb/IIIa platelet receptor antagonist tirofiban does not increase cerebral…
